Sfoglia per Rivista VALUE IN HEALTH
RECURRENT LARYNGEAL CARCINOMA PET STUDY (RELAPS): COST ANALYSIS OF 18F-FDG PET IN PATIENTS WITH SUSPECTED RECURRENT LARYNGEAL CANCER PREVIOUSLY TREATED WITH RADIOTHERAPY
2015-01-01 Zaim, R; van der Putten, L; de Groot, S; van Tinteren, H; Boers, M; Comans, E; van der Laan, B; Janssen, L; Takes, R; van den Brekel, M; Oyen, W; Valdes-Olmos, R; Hobbelink, M; Wedman, J; Leemans, C; Hoekstra, O; de Bree, R; Uyl-de Groot, C
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES
2019-01-01 Lorenzoni, V; Convertino, I; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Cazzato, M; Blandizzi, C; Gini, R; Tuccori, M; Mosca, M; Turchetti, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| RECURRENT LARYNGEAL CARCINOMA PET STUDY (RELAPS): COST ANALYSIS OF 18F-FDG PET IN PATIENTS WITH SUSPECTED RECURRENT LARYNGEAL CANCER PREVIOUSLY TREATED WITH RADIOTHERAPY | 1-gen-2015 | Zaim, R; van der Putten, L; de Groot, S; van Tinteren, H; Boers, M; Comans, E; van der Laan, B; Janssen, L; Takes, R; van den Brekel, M; Oyen, W; Valdes-Olmos, R; Hobbelink, M; Wedman, J; Leemans, C; Hoekstra, O; de Bree, R; Uyl-de Groot, C | |
| THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES | 1-gen-2019 | Lorenzoni, V; Convertino, I; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Cazzato, M; Blandizzi, C; Gini, R; Tuccori, M; Mosca, M; Turchetti, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile